Immunomodulatory effects and mechanisms of Tiepishihu Xiyangshen granules on cyclophosphamide induced immuno-suppression via TLR4/MAPKs and PI3K/AKT/FOXO3a signal pathways

免疫系统 脾脏 蛋白激酶B 淋巴细胞 免疫学 生物 药理学 免疫抑制 医学 信号转导 细胞生物学
作者
Nan Hu,Yue Qu,Tingyu Liu,Yue Zhou,Chang Liu,Jinhui Wang,Baofeng Yang,Chun-li Li
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:307: 116192-116192 被引量:6
标识
DOI:10.1016/j.jep.2023.116192
摘要

Tiepishihu Xiyangshen granules (TXG) is a traditional Chinese medicine formula composed of Panax quinquefolius L, Dendrobium officinale Kimura & Migo and Ganoderma lucidum (Curtis) P. Karst. It has long been used as a nutritional supplement and an immune enhancer in China. However, the immunomodulatory effects and the underlying mechanisms of TXG have not been clarified. This study aims to investigate the immunomodulatory effects of TXG and clarify the underlying mechanism. TXG was administered by gavage for 18 days. From the 15th day, the immunosuppression model was induced by intraperitoneally injecting 80 mg/kg CTX for 3 days. The immune regulatory effects of TXG on immune organs were verified by calculating the organ index and observing the spleen tissue structure through HE staining. The effects of TXG on immune cells were examined by recording the PBWC, the proliferation rate of lymphocyte and the T lymphocyte phenotype. The effects of TXG on immune molecules were measured by detecting serum hemolysin and the content of cytokines. In parallel, kit was utilized to detect its antioxidant capacity. RNA seq and Western blot were used to analyze the possible immune regulation mechanism of TXG. HPLC and UPLC-Q-TOF-MS were used to identify the chemical components in TXG. At the level of immune organs, TXG effectively reduced the adverse reaction to the body and the substantial damage to the spleen after chemotherapy by improving the spleen damage. At the level of immune molecules, TXG upregulated the expression of cytokines and antibodies. At the level of immune cells, TXG antagonized bone marrow suppression by increasing the PBWC of immunosuppressed mice. Meanwhile, TXG upregulated the ratio of CD4+/CD8+ lymphocytes and ameliorated the proliferation of T and B lymphocytes. And the mechanism of TXG to improve immunity might be through TLR4/MAPKs and PI3K/AKT/FOXO3a signaling pathways. The results of this study confirmed that TXG has prominent immunomodulatory activities, and the immunity regulations of TXG may be achieved by regulating TLR4/MAPKs and PI3K/AKT/FOXO3a signal pathways.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
你好发布了新的文献求助60
1秒前
诚心代芙完成签到 ,获得积分10
2秒前
2秒前
幸福妙柏完成签到 ,获得积分10
4秒前
可cabd完成签到,获得积分10
6秒前
6秒前
6秒前
小二郎应助繁荣的又夏采纳,获得10
7秒前
pupuply完成签到,获得积分10
7秒前
Zachary完成签到,获得积分10
9秒前
qq完成签到,获得积分10
9秒前
10秒前
YY发布了新的文献求助10
10秒前
cwn完成签到 ,获得积分10
10秒前
隐形的巴豆完成签到,获得积分10
10秒前
赘婿应助天苍野茫采纳,获得30
11秒前
这个大头张呀完成签到,获得积分10
12秒前
12秒前
12秒前
ahua发布了新的文献求助10
13秒前
飘逸锦程完成签到 ,获得积分10
13秒前
不安青牛应助科研通管家采纳,获得20
13秒前
共享精神应助科研通管家采纳,获得10
13秒前
14秒前
小包应助科研通管家采纳,获得10
14秒前
一一应助科研通管家采纳,获得10
14秒前
Meyako应助科研通管家采纳,获得10
14秒前
情怀应助科研通管家采纳,获得10
14秒前
14秒前
在水一方应助科研通管家采纳,获得30
14秒前
Jasper应助科研通管家采纳,获得10
14秒前
14秒前
Zachary发布了新的文献求助10
14秒前
一一应助科研通管家采纳,获得10
14秒前
15秒前
Lucas应助科研通管家采纳,获得10
15秒前
Akim应助科研通管家采纳,获得10
15秒前
科研通AI5应助科研通管家采纳,获得10
15秒前
15秒前
DijiaXu应助科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Voyage au bout de la révolution: de Pékin à Sochaux 700
Methodology for the Human Sciences 500
First Farmers: The Origins of Agricultural Societies, 2nd Edition 500
Simulation of High-NA EUV Lithography 400
Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 400
The Rise & Fall of Classical Legal Thought 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4332525
求助须知:如何正确求助?哪些是违规求助? 3844534
关于积分的说明 12009414
捐赠科研通 3485109
什么是DOI,文献DOI怎么找? 1912706
邀请新用户注册赠送积分活动 956259
科研通“疑难数据库(出版商)”最低求助积分说明 857095